Clinical Trial Update: Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intravenous rhPro-UK given before thrombectomy in acute ischemic stroke patients in an extended time window; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• rhPro-UK (recombinant human pro-urokinase)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: NOT_YET_RECRUITING